Zena Willsmore

557 total citations
10 papers, 108 citations indexed

About

Zena Willsmore is a scholar working on Immunology, Oncology and Dermatology. According to data from OpenAlex, Zena Willsmore has authored 10 papers receiving a total of 108 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Oncology and 2 papers in Dermatology. Recurrent topics in Zena Willsmore's work include Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (4 papers) and CAR-T cell therapy research (2 papers). Zena Willsmore is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (4 papers) and CAR-T cell therapy research (2 papers). Zena Willsmore collaborates with scholars based in United Kingdom, United States and Canada. Zena Willsmore's co-authors include Sophia N. Karagiannis, Gary Middleton, Andrew Cope, Mark T. Drayson, Katie E. Lacy, Alex Richter, Jenny L. C. Geh, Sophie Papa, Akshay J. Patel and Babu Naidu and has published in prestigious journals such as Nature Communications, Annals of the Rheumatic Diseases and Journal for ImmunoTherapy of Cancer.

In The Last Decade

Zena Willsmore

10 papers receiving 105 citations

Peers

Zena Willsmore

ONCOL

IMMUN

PRM

DERMA

Nathalie Dhomen United Kingdom

Caroline Ang Australia

Niko Thio Australia

Miguel Caballero‐Baños Spain

Anamarija Markota Germany

Simone Ostrouska Australia

Ekaterina Postovalova United States

Charlotte J. Imianowski United Kingdom

Esther Hian Li Chan Singapore

Nikolaus Jahn Germany

Nathalie Dhomen United Kingdom

Zena Willsmore

110 ×1.4

ONCOL

84 ×1.3

IMMUN

35 ×1.3

16 ×1.3

PRM

7 ×0.6

DERMA

Citations per year, relative to Zena Willsmore Zena Willsmore (= 1×) peers Nathalie Dhomen

Countries citing papers authored by Zena Willsmore

Since Specialization

Citations

This map shows the geographic impact of Zena Willsmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zena Willsmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zena Willsmore more than expected).

Fields of papers citing papers by Zena Willsmore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zena Willsmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zena Willsmore. The network helps show where Zena Willsmore may publish in the future.

Co-authorship network of co-authors of Zena Willsmore

This figure shows the co-authorship network connecting the top 25 collaborators of Zena Willsmore. A scholar is included among the top collaborators of Zena Willsmore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zena Willsmore. Zena Willsmore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Willsmore, Zena, Lucy H. Booth, Akshay J. Patel, et al.. (2025). Circulating immunoregulatory B cell and autoreactive antibody profiles predict lack of toxicity to anti-PD-1 checkpoint inhibitor treatment in advanced melanoma. Journal for ImmunoTherapy of Cancer. 13(5). e011682–e011682. 2 indexed citations

Habib, Shabana, Gabriel Osborn, Zena Willsmore, et al.. (2024). Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma. Expert Review of Clinical Immunology. 20(8). 895–911. 10 indexed citations

Patel, Akshay J., Zena Willsmore, Naeem Khan, et al.. (2022). Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade. Nature Communications. 13(1). 3148–3148. 41 indexed citations

Harris, R. J. C., Zena Willsmore, Roman Laddach, et al.. (2022). Enriched circulating and tumor-resident TGF-β ⁺ regulatory B cells in patients with melanoma promote FOXP3 ⁺ Tregs. OncoImmunology. 11(1). 2104426–2104426. 26 indexed citations

Osborn, Gabriel, Roman Laddach, Zena Willsmore, et al.. (2022). Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies. OncoImmunology. 11(1). 2127284–2127284. 16 indexed citations

Robson, Alistair, Ellie Rashidghamat, Zena Willsmore, et al.. (2021). Follicular T-Helper Cells in Marginal Zone Lymphoma: Evidence of an Organoid Immune Response. American Journal of Dermatopathology. 43(12). e197–e203. 8 indexed citations

Robson, Alistair, et al.. (2021). A Problem of Classification: 2 Cases of Epstein–Barr Virus + Primary Cutaneous Plasmacytoma Arising in Immunocompetent Elderly Patients. American Journal of Dermatopathology. 43(12). e237–e240. 1 indexed citations

Rashidghamat, Ellie, et al.. (2021). Follicular T-Helper Cells in Marginal Zone Lymphoma: Evidence of an Organoid Immune Response.. PubMed. 43(12). e197–e203. 1 indexed citations

Kempf, Werner, et al.. (2021). A Problem of Classification: 2 Cases of Epstein–Barr Virus + Primary Cutaneous Plasmacytoma Arising in Immunocompetent Elderly Patients. Zurich Open Repository and Archive (University of Zurich). 1 indexed citations

10.

Hughes, Catherine, Bina Menon, Richard Woolf, et al.. (2020). SAT0376 DOES SUPPRESSION OF IL-4 AND IL-13 LEAD TO THE DEVELOPMENT OF NEW ONSET SPONDYLO-ARTHRITIS IN SUSCEPTIBLE PATIENTS?. Annals of the Rheumatic Diseases. 79. 1136–1136. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact